Celemics, Inc. (KOSDAQ:331920)

Market Cap	38.21B +36.2%
Revenue (ttm)	6.13B +2.0%
Net Income	-12.56B
EPS	-1,539.90
Shares Out	8.16M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	185,015
Average Volume	570,885
Open	4,885.00
Previous Close	4,685.00
Day's Range	4,395.00 - 4,885.00
52-Week Range	2,535.00 - 5,390.00
Beta	0.77
RSI	64.38
Earnings Date	Mar 20, 2026

About Celemics

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development se...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2010
• Employees: 40
• Stock Exchange: KOSDAQ
• Ticker Symbol: 331920